Source: Eur Respir J 2016; 47:1472-1480
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Overgaard Dorthe, Kaldan Gudrun, Marsaa Kristoffer, Nielsen Thyge Lynghøj, Shaker Saher Burhan, Egerod Ingrid. The lived experience with idiopathic pulmonary fibrosis: a qualitative study. Eur Respir J 2016; 47:1472-1480

Member's Comments

No comment yet.

Related content which might interest you: Perceptions, experiences and information needs of patients with idiopathic pulmonary fibrosis (IPF): A qualitative study Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 The lived experience of idiopatic pulmonary fibrosis: A qualitative study Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 Communication difficulties reported by patients diagnosed with idiopathic pulmonary fibrosis and their carers: a European focus group study Source: ERJ Open Res, 5 (2) 00055-2019; 10.1183/23120541.00055-2019 Year: 2019 Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study Source: Eur Respir J 2004; 24: Suppl. 48, 254s Year: 2004 Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018 Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 The illness perceptions in chronic obstructive pulmonary disease: a qualitative study Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Patients and families realizing their future with chronic obstructive pulmonary disease - a qualitative study Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 The last year of life of chronic obstructive pulmonary disease (COPD) patients: a qualitative study of carers' accounts Source: Eur Respir J 2001; 18: Suppl. 33, 348s Year: 2001 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study. Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018